MyFinsight
Home
About
Contact
brns: the income statement
Download
Download image
Net loss
attributable to barinthus...
-$14,566K
(-79.52%↓ Y/Y)
Net loss
attributable to...
-$5K
(66.67%↑ Y/Y)
Net loss
-$14,571K
(-79.25%↓ Y/Y)
Tax benefit
-$71K
(-2266.67%↓ Y/Y)
Research and development
incentives
$240K
(-60.53%↓ Y/Y)
Interest income
$472K
(-25.20%↓ Y/Y)
Loss before income
tax
-$14,642K
(-80.05%↓ Y/Y)
Total other income,
net
$424K
(-66.03%↓ Y/Y)
Other income
-$275K
(-1157.69%↓ Y/Y)
Interest expense
$13K
(-23.53%↓ Y/Y)
Loss from operations
-$15,066K
(-60.62%↓ Y/Y)
Other operating
income
$156K
(-25.71%↓ Y/Y)
Total operating
expenses
$15,222K
(-38.02%↓ Y/Y)
Impairment of long-lived
assets
$4,667K
General and
administrative
$5,165K
(-61.51%↓ Y/Y)
Research and development
$5,390K
(-51.61%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Barinthus Biotherapeutics plc. (BRNS)
Barinthus Biotherapeutics plc. (BRNS)